首页 > 最新文献

American journal of obstetrics and gynecology最新文献

英文 中文
Rethinking “Obstetric violence”: a misnomer indeed "产科暴力 "的确是个误解。
IF 8.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.ajog.2024.07.013
Frank A. Chervenak MD, Amos Grünebaum MD
{"title":"Rethinking “Obstetric violence”: a misnomer indeed","authors":"Frank A. Chervenak MD, Amos Grünebaum MD","doi":"10.1016/j.ajog.2024.07.013","DOIUrl":"10.1016/j.ajog.2024.07.013","url":null,"abstract":"","PeriodicalId":7574,"journal":{"name":"American journal of obstetrics and gynecology","volume":"232 2","pages":"Page e52"},"PeriodicalIF":8.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141619021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Restricted physical activity and maternal rest improve fetal growth 限制体力活动和产妇休息可促进胎儿生长。
IF 8.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.ajog.2024.08.003
Greggory R. DeVore MD, Bardo Polanco PhD, RDMS, Wesley Lee MD, Jeffrey Brian Fowlkes PhD, Emma E. Peek BS, Manesha Putra MD, John C. Hobbins MD
{"title":"Restricted physical activity and maternal rest improve fetal growth","authors":"Greggory R. DeVore MD, Bardo Polanco PhD, RDMS, Wesley Lee MD, Jeffrey Brian Fowlkes PhD, Emma E. Peek BS, Manesha Putra MD, John C. Hobbins MD","doi":"10.1016/j.ajog.2024.08.003","DOIUrl":"10.1016/j.ajog.2024.08.003","url":null,"abstract":"","PeriodicalId":7574,"journal":{"name":"American journal of obstetrics and gynecology","volume":"232 2","pages":"Page e63"},"PeriodicalIF":8.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141905570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of and risk factors for endometrial polyps among asymptomatic postmenopausal women with uterovaginal prolapse 子宫阴道脱垂的无症状绝经后妇女中子宫内膜息肉的患病率和风险因素。
IF 8.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.ajog.2024.08.001
Gabriela M. Weigel MD , George N. Baison MD , Linda Mihalov MD , Tariro Mupombwa MD

Background

The prevalence of endometrial polyps among asymptomatic, postmenopausal women is not well defined. There is no clear clinical consensus on how to manage endometrial polyps in this population and whether these polyps truly are a cause for clinical concern.

Objective

This study aimed to estimate the prevalence of endometrial polyps among asymptomatic (without bleeding), postmenopausal women and to evaluate risk factors associated with their presence.

Study Design

This cross-sectional study assessed the prevalence of endometrial polyps among asymptomatic, postmenopausal women who underwent a hysterectomy for uterovaginal prolapse. Patients were excluded if they underwent a hysterectomy for other indications, including postmenopausal bleeding. Following chart review, eligible patients who received care at a single site in Washington state from 2009 to 2018 were included. The primary outcome was the presence of endometrial polyps on pathology. Risk factors associated with polyp prevalence were subsequently assessed using univariate analysis and multivariate regression.

Results

Of the 317 eligible women identified, endometrial polyps were identified in 106 women (33.4%). The average polyp size and endometrial thickness was 13±10 mm and 1.4±1.5 mm, respectively. Most cases (78%) had solitary polyps. Premalignant and malignant lesions were found in 2 cases (1.89%); 1 had endometrial carcinoma and 1 had endometrial intraepithelial neoplasia. Baseline clinical and demographic characteristics were similar between patients with and those without endometrial polyps, including the presence of fibroids, endometriosis, and adenomyosis. A multivariate logistic regression showed that the presence of polyps was independently associated with a high body mass index (odds ratio, 1.06; 95% confidence interval, 1.01–1.12; P=.02) and use of menopausal hormone therapy (odds ratio, 1.67; 95% confidence interval, 1.02–2.72; P=.04).

Conclusion

Asymptomatic postmenopausal women who underwent hysterectomy for uterovaginal prolapse exhibited a high prevalence of endometrial polyps. Those who used menopausal hormone therapy and who had a high body mass index were at a higher risk for developing endometrial polyps. Although the risk for malignancy seems to be low, more investigation is warranted to truly quantify the lifetime risk. For now, expectant management may be a reasonable approach for incidentally found, asymptomatic polyps.
背景:绝经后无症状妇女的子宫内膜息肉发病率尚不明确。对于如何处理这类人群中的子宫内膜息肉以及这些息肉是否真的需要引起临床关注,临床上还没有达成明确的共识:研究设计:这项横断面研究评估了因子宫阴道脱垂而接受子宫切除术的无症状绝经后妇女中子宫内膜息肉的患病率。因绝经后出血等其他适应症而接受子宫切除术的患者不包括在内。病历审查包括 2009 年至 2018 年期间在华盛顿州单个地点接受治疗的符合条件的患者。主要结果是病理检查发现子宫内膜息肉。随后使用单变量分析和多变量回归评估了与息肉患病率相关的风险因素:在 317 名符合条件的妇女中,有 106 名妇女(33.4%)被查出患有子宫内膜息肉。息肉的平均大小和内膜厚度分别为 13 +/- 10 毫米和 1.4 +/- 1.5 毫米。大多数病例(78%)为单发息肉。有 2 例(1.89%)发现了癌前病变和恶性病变;其中一例为子宫内膜癌,一例为子宫内膜上皮内瘤变。有子宫内膜息肉和无子宫内膜息肉患者的基线临床和人口统计学特征相似,包括是否存在子宫肌瘤、子宫内膜异位症和子宫腺肌症。多变量逻辑回归显示,息肉的存在与高体重指数(OR 1.06,95%-CI 1.01-1.12,P 值 0.02)和使用绝经激素治疗(OR 1.67,95%-CI 1.02-2.72,P 值 0.04)独立相关:结论:因子宫阴道脱垂而接受子宫切除术的绝经后无症状妇女的子宫内膜息肉发病率较高。使用绝经激素治疗和体重指数高的妇女患子宫内膜息肉的风险更高。虽然恶性风险似乎很低,但要真正量化终生风险,还需要进行更多的调查。目前,对于偶然发现的无症状息肉,预期治疗可能是一种合理的方法。
{"title":"Prevalence of and risk factors for endometrial polyps among asymptomatic postmenopausal women with uterovaginal prolapse","authors":"Gabriela M. Weigel MD ,&nbsp;George N. Baison MD ,&nbsp;Linda Mihalov MD ,&nbsp;Tariro Mupombwa MD","doi":"10.1016/j.ajog.2024.08.001","DOIUrl":"10.1016/j.ajog.2024.08.001","url":null,"abstract":"<div><h3>Background</h3><div>The prevalence of endometrial polyps among asymptomatic, postmenopausal women is not well defined. There is no clear clinical consensus on how to manage endometrial polyps in this population and whether these polyps truly are a cause for clinical concern.</div></div><div><h3>Objective</h3><div>This study aimed to estimate the prevalence of endometrial polyps among asymptomatic (without bleeding), postmenopausal women and to evaluate risk factors associated with their presence.</div></div><div><h3>Study Design</h3><div>This cross-sectional study assessed the prevalence of endometrial polyps among asymptomatic, postmenopausal women who underwent a hysterectomy for uterovaginal prolapse. Patients were excluded if they underwent a hysterectomy for other indications, including postmenopausal bleeding. Following chart review, eligible patients who received care at a single site in Washington state from 2009 to 2018 were included. The primary outcome was the presence of endometrial polyps on pathology. Risk factors associated with polyp prevalence were subsequently assessed using univariate analysis and multivariate regression.</div></div><div><h3>Results</h3><div>Of the 317 eligible women identified, endometrial polyps were identified in 106 women (33.4%). The average polyp size and endometrial thickness was 13±10 mm and 1.4±1.5 mm, respectively. Most cases (78%) had solitary polyps. Premalignant and malignant lesions were found in 2 cases (1.89%); 1 had endometrial carcinoma and 1 had endometrial intraepithelial neoplasia. Baseline clinical and demographic characteristics were similar between patients with and those without endometrial polyps, including the presence of fibroids, endometriosis, and adenomyosis. A multivariate logistic regression showed that the presence of polyps was independently associated with a high body mass index (odds ratio, 1.06; 95% confidence interval, 1.01–1.12; <em>P</em>=.02) and use of menopausal hormone therapy (odds ratio, 1.67; 95% confidence interval, 1.02–2.72; <em>P</em>=.04).</div></div><div><h3>Conclusion</h3><div>Asymptomatic postmenopausal women who underwent hysterectomy for uterovaginal prolapse exhibited a high prevalence of endometrial polyps. Those who used menopausal hormone therapy and who had a high body mass index were at a higher risk for developing endometrial polyps. Although the risk for malignancy seems to be low, more investigation is warranted to truly quantify the lifetime risk. For now, expectant management may be a reasonable approach for incidentally found, asymptomatic polyps.</div></div>","PeriodicalId":7574,"journal":{"name":"American journal of obstetrics and gynecology","volume":"232 2","pages":"Pages 196.e1-196.e6"},"PeriodicalIF":8.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141911340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Defining mode of delivery as ‘instrumental vaginal delivery’: are results generalizable to both forceps and vacuum? 将分娩方式定义为 "器械性阴道分娩":结果是否适用于产钳和真空助产?
IF 8.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.ajog.2024.08.021
Giulia M. Muraca PhD, MPH
{"title":"Defining mode of delivery as ‘instrumental vaginal delivery’: are results generalizable to both forceps and vacuum?","authors":"Giulia M. Muraca PhD, MPH","doi":"10.1016/j.ajog.2024.08.021","DOIUrl":"10.1016/j.ajog.2024.08.021","url":null,"abstract":"","PeriodicalId":7574,"journal":{"name":"American journal of obstetrics and gynecology","volume":"232 2","pages":"Page e53"},"PeriodicalIF":8.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142016087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
First trimester anomaly scan in the national screening program 国家筛查计划中的妊娠头三个月异常扫描。
IF 8.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.ajog.2024.08.038
Avir Sarkar, Aabir Humam, Huda Faisal, Iffat Maab
{"title":"First trimester anomaly scan in the national screening program","authors":"Avir Sarkar,&nbsp;Aabir Humam,&nbsp;Huda Faisal,&nbsp;Iffat Maab","doi":"10.1016/j.ajog.2024.08.038","DOIUrl":"10.1016/j.ajog.2024.08.038","url":null,"abstract":"","PeriodicalId":7574,"journal":{"name":"American journal of obstetrics and gynecology","volume":"232 2","pages":"Page e81"},"PeriodicalIF":8.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142103526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reduced number of regulatory T cells in maternal circulation precede idiopathic spontaneous preterm labor in a subset of patients 减少数量的调节性T细胞在母体循环先于特发性自发性早产患者的一个子集。
IF 8.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.ajog.2024.11.001
Michal Koucky MD, PhD , Zdenek Lastuvka MD, PhD , Helena Koprivova Mgr , Tereza Cindrova-Davies MD, PhD , Jiri Hrdy RNDr, PhD , Karin Cerna MD , Pavel Calda MD, CSc

Background

Accumulating evidence suggests that spontaneous preterm labor is a syndrome caused by multiple pathological processes. The breakdown of maternal-fetal tolerance has been proposed as a key mechanism of idiopathic spontaneous preterm labor, often viewed as a chronic inflammatory process resulting from the maternal immune system's impaired tolerance of the fetus from early pregnancy. Regulatory T cells are crucial for maintaining maternal-fetal tolerance. Even a partial reduction in their levels can disrupt this tolerance, leading to adverse pregnancy outcomes such as preterm labor. Given the complexity of the T lymphocyte-mediated immune response, identifying candidate signaling pathways involved in maternal-fetal tolerance is challenging. However, current literature highlights the importance of the functional and developmental markers FoxP3, CD45RA, Helios, and CD39 due to their immunosuppressive abilities essential for maintaining pregnancy.

Objective

This study aimed to determine whether changes in numbers of selected regulatory T cell subpopulations in the first trimester are associated with subsequent spontaneous preterm labor.

Study Design

This prospective study enrolled 43 women with early singleton pregnancies, excluding those with autoimmune diseases, diabetes mellitus (type 1, type 2), primary hypertension, or who had been treated with vaginal progesterone prior to sample collection. We analyzed regulatory T cell subpopulations in maternal circulation using the DURAClone IM T cell kit, focusing on the following subsets: CD4+CD25+FoxP3+, CD4+CD25+FoxP3+CD45RA, CD4+CD25+FoxP3+Helios+, and CD4+CD25+FoxP3+CD39−.

Results

Among the participants, 7 experienced spontaneous preterm labor between the 23rd and 33rd weeks of gestation, while 36 delivered at term. The preterm group showed a significant reduction in numbers of all analyzed regulatory T cell subpopulations: CD4+CD25+FoxP3+ (median 0.0410×10ˆ9/L vs median 0.0550×10ˆ9/L, P=.0217), CD4+CD25+FoxP3+CD45RA− (median 0.0310×10ˆ9/L vs median 0.0420×10ˆ9/L, P=.0216), CD4+CD25+FoxP3+Helios+ (median 0.0270×10ˆ9/L vs median 0.0370×10ˆ9/L, P=.0260), CD4+CD25+FoxP3+CD39− (median 0.0300×10ˆ9/L vs median 0.0420×10ˆ9/L, P=.0427).

Conclusion

Early first trimester alterations in specific regulatory T cell subpopulations, including diminished levels of CD4+CD25+FoxP3+, CD4+CD25+FoxP3+CD45RA−, CD4+CD25+FoxP3+Helios+, and CD4+CD25+FoxP3+CD39−, are associated with idiopathic spontaneous preterm labor. These findings suggest that early changes in these lymphocyte subpopulations may be linked to spontaneous preterm birth. This highlights the need for further research to understand the mechanisms underlying regulatory T-cell dynamics and their impact on pregnancy outcomes.
背景:越来越多的证据表明自发性早产是一种由多种病理过程引起的综合征。母体-胎儿耐受性的破坏被认为是特发性自发性早产的一个关键机制,通常被认为是由于母体免疫系统在妊娠早期对胎儿的耐受性受损而导致的慢性炎症过程。调节性T细胞对维持母胎耐受性至关重要。即使它们水平的部分降低也会破坏这种耐受性,导致不良的妊娠结果,如早产。鉴于T淋巴细胞介导的免疫反应的复杂性,确定参与母胎耐受的候选信号通路是具有挑战性的。然而,目前的文献强调了功能和发育标记FoxP3、CD45RA、Helios和CD39的重要性,因为它们的免疫抑制能力对维持妊娠至关重要。目的:本研究旨在确定妊娠早期选择性调节性T细胞亚群数量的变化是否与随后的自发性早产有关。研究设计:这项前瞻性研究纳入了43名早期单胎妊娠的妇女,排除了那些患有自身免疫性疾病、糖尿病(1型、2型)、原发性高血压或在样本采集前接受过阴道孕酮治疗的妇女。我们使用DURAClone IM T细胞试剂盒分析了母体循环中的调节性T细胞亚群,重点关注以下亚群:CD4+CD25+FoxP3+, CD4+CD25+FoxP3+CD45RA, CD4+CD25+FoxP3+Helios+和CD4+CD25+FoxP3+CD39-。结果:7例在妊娠23 ~ 33周发生自然早产,36例足月分娩。早产组显示所有分析的调节性T细胞亚群的数量显著减少:CD4+CD25+FoxP3+(中位数0.0410×10º9/L vs中位数0.0550×10º9/L, P= 0.0217), CD4+CD25+FoxP3+CD45RA-(中位数0.0310×10º9/L vs中位数0.0420×10º9/L, P= 0.0216), CD4+CD25+FoxP3+Helios+(中位数0.0270×10º9/L vs中位数0.0370×10º9/L, P= 0.0260), CD4+CD25+FoxP3+CD39-(中位数0.0300×10º9/L vs中位数0.0420×10º9/L, P= 0.0427)。结论:孕早期特异性调节性T细胞亚群的改变,包括CD4+CD25+FoxP3+、CD4+CD25+FoxP3+CD45RA-、CD4+CD25+FoxP3+Helios+和CD4+CD25+FoxP3+CD39-水平的降低,与特发性自发性早产有关。这些发现表明,这些淋巴细胞亚群的早期变化可能与自发性早产有关。这突出了进一步研究的必要性,以了解调节t细胞动力学的机制及其对妊娠结局的影响。
{"title":"Reduced number of regulatory T cells in maternal circulation precede idiopathic spontaneous preterm labor in a subset of patients","authors":"Michal Koucky MD, PhD ,&nbsp;Zdenek Lastuvka MD, PhD ,&nbsp;Helena Koprivova Mgr ,&nbsp;Tereza Cindrova-Davies MD, PhD ,&nbsp;Jiri Hrdy RNDr, PhD ,&nbsp;Karin Cerna MD ,&nbsp;Pavel Calda MD, CSc","doi":"10.1016/j.ajog.2024.11.001","DOIUrl":"10.1016/j.ajog.2024.11.001","url":null,"abstract":"<div><h3>Background</h3><div>Accumulating evidence suggests that spontaneous preterm labor is a syndrome caused by multiple pathological processes. The breakdown of maternal-fetal tolerance has been proposed as a key mechanism of idiopathic spontaneous preterm labor, often viewed as a chronic inflammatory process resulting from the maternal immune system's impaired tolerance of the fetus from early pregnancy. Regulatory T cells are crucial for maintaining maternal-fetal tolerance. Even a partial reduction in their levels can disrupt this tolerance, leading to adverse pregnancy outcomes such as preterm labor. Given the complexity of the T lymphocyte-mediated immune response, identifying candidate signaling pathways involved in maternal-fetal tolerance is challenging. However, current literature highlights the importance of the functional and developmental markers FoxP3, CD45RA, Helios, and CD39 due to their immunosuppressive abilities essential for maintaining pregnancy.</div></div><div><h3>Objective</h3><div>This study aimed to determine whether changes in numbers of selected regulatory T cell subpopulations in the first trimester are associated with subsequent spontaneous preterm labor.</div></div><div><h3>Study Design</h3><div>This prospective study enrolled 43 women with early singleton pregnancies, excluding those with autoimmune diseases, diabetes mellitus (type 1, type 2), primary hypertension, or who had been treated with vaginal progesterone prior to sample collection. We analyzed regulatory T cell subpopulations in maternal circulation using the DURAClone IM T cell kit, focusing on the following subsets: CD4+CD25+FoxP3+, CD4+CD25+FoxP3+CD45RA, CD4+CD25+FoxP3+Helios+, and CD4+CD25+FoxP3+CD39−.</div></div><div><h3>Results</h3><div>Among the participants, 7 experienced spontaneous preterm labor between the 23rd and 33rd weeks of gestation, while 36 delivered at term. The preterm group showed a significant reduction in numbers of all analyzed regulatory T cell subpopulations: CD4+CD25+FoxP3+ (median 0.0410×10ˆ9/L vs median 0.0550×10ˆ9/L, <em>P</em>=.0217), CD4+CD25+FoxP3+CD45RA− (median 0.0310×10ˆ9/L vs median 0.0420×10ˆ9/L, <em>P</em>=.0216), CD4+CD25+FoxP3+Helios+ (median 0.0270×10ˆ9/L vs median 0.0370×10ˆ9/L, <em>P</em>=.0260), CD4+CD25+FoxP3+CD39− (median 0.0300×10ˆ9/L vs median 0.0420×10ˆ9/L, <em>P</em>=.0427).</div></div><div><h3>Conclusion</h3><div>Early first trimester alterations in specific regulatory T cell subpopulations, including diminished levels of CD4+CD25+FoxP3+, CD4+CD25+FoxP3+CD45RA−, CD4+CD25+FoxP3+Helios+, and CD4+CD25+FoxP3+CD39−, are associated with idiopathic spontaneous preterm labor. These findings suggest that early changes in these lymphocyte subpopulations may be linked to spontaneous preterm birth. This highlights the need for further research to understand the mechanisms underlying regulatory T-cell dynamics and their impact on pregnancy outcomes.</div></div>","PeriodicalId":7574,"journal":{"name":"American journal of obstetrics and gynecology","volume":"232 2","pages":"Pages 222.e1-222.e11"},"PeriodicalIF":8.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142913717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of COVID-19 pandemic on postpartum depression and contraception Covid-19 大流行对产后抑郁和避孕的影响。
IF 8.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.ajog.2024.08.020
Chloe N. Matovina MD, MA, Allie Sakowicz MD, MS, Emma C. Allen MD, MEd, Mayán I. Alvarado-Goldberg, Danielle Millan BA, Emily S. Miller MD, MPH
{"title":"Effect of COVID-19 pandemic on postpartum depression and contraception","authors":"Chloe N. Matovina MD, MA,&nbsp;Allie Sakowicz MD, MS,&nbsp;Emma C. Allen MD, MEd,&nbsp;Mayán I. Alvarado-Goldberg,&nbsp;Danielle Millan BA,&nbsp;Emily S. Miller MD, MPH","doi":"10.1016/j.ajog.2024.08.020","DOIUrl":"10.1016/j.ajog.2024.08.020","url":null,"abstract":"","PeriodicalId":7574,"journal":{"name":"American journal of obstetrics and gynecology","volume":"232 2","pages":"Page e48"},"PeriodicalIF":8.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142003388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accuracy of antenatal ultrasound in predicting large-for-gestational-age babies: population-based cohort study 产前超声波预测巨大胎儿的准确性:基于人群的队列研究。
IF 8.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.ajog.2024.04.052
Lauren J. Ewington PhD , Oliver Hugh MSc , Emily Butler BSc (Hons) , Siobhan Quenby MD, FRCOG , Jason Gardosi MD, FRCOG
<div><h3>Background</h3><div>Pregnancies with large-for-gestational-age fetuses are at increased risk of adverse maternal and neonatal outcomes. There is uncertainty about how to manage birth in such pregnancies. Current guidelines recommend a discussion with women of the pros and cons of options, including expectant management, induction of labor, and cesarean delivery. For women to make an informed decision about birth, antenatal detection of large for gestational age is essential.</div></div><div><h3>Objective</h3><div>To investigate the ability of antenatal ultrasound scans to predict large for gestational age at birth.</div></div><div><h3>Study Design</h3><div>In this retrospective cohort study, we analyzed data from a routinely collected database from the West Midlands, United Kingdom. We included pregnancies that had an antenatal ultrasound-estimated fetal weight between 35+0 and 38+0 weeks gestation for any indication and a subgroup where the reason for the scan was that the fetus was suspected to be big. Large for gestational age was defined as >90th customized GROW percentile for estimated fetal weight as well as neonatal weight. In addition, we tested the performance of an uncustomized standard, with Hadlock fetal weight >90th percentile and neonatal weight >4 kg. We calculated diagnostic characteristics for the whole population and groups with different maternal body mass indexes.</div></div><div><h3>Results</h3><div>The study cohort consisted of 26,527 pregnancies, which, on average, had a scan at 36+4 weeks gestation and delivered 20 days later at a median of 39+3 weeks (interquartile range 15). In total, 2241 (8.4%) of neonates were large for gestational age by customized percentiles, of which 1459 (65.1%) had a scan estimated fetal weight >90th percentile, with a false positive rate of 8.6% and a positive predictive value of 41.0%. In the subgroup of 912 (3.4%) pregnancies scanned for a suspected large fetus, 293 (32.1%) babies were large for gestational age at birth, giving a positive predictive value of 50.3%, with a sensitivity of 77.1% and false positive rate of 36.0%. When comparing subgroups from low (<18.5 kg/m<sup>2</sup>) to high body mass index (>30 kg/m<sup>2</sup>), sensitivity increased from 55.6% to 67.8%, false positive rate from 5.2% to 11.5%, and positive predictive value from 32.1% to 42.3%. A total of 2585 (9.7%) babies were macrosomic (birthweight >4 kg), and of these, 1058 (40.9%) were large for gestational age (>90th percentile) antenatally by Hadlock’s growth standard, with a false positive rate of 4.9% and a positive predictive value 41.0%. Analysis within subgroups showed better performance by customized than uncustomized standards for low body mass index (<18.5; diagnostic odds ratio, 23.0 vs 6.4) and high body mass index (>30; diagnostic odds ratio, 16.2 vs 8.8).</div></div><div><h3>Conclusion</h3><div>Late third-trimester ultrasound estimation of fetal weight for any indica
背景:孕龄较大胎儿的孕妇发生不良孕产结局和新生儿结局的风险较高。如何处理这类孕妇的分娩问题还存在不确定性。现行指南建议与孕妇讨论各种选择的利弊,包括预产期管理、引产和剖腹产。为了让妇女能够对分娩做出明智的决定,产前检测胎龄过大至关重要:研究设计:在这项回顾性队列研究中,我们分析了英国西米德兰兹地区常规数据库中的数据。我们纳入了在妊娠 35+0 周至 38+0 周之间进行产前超声估测胎儿体重的孕妇,无论其原因是什么,以及扫描原因是怀疑胎儿巨大的亚组。胎龄过大是指胎儿体重和新生儿体重的估计值均大于第 90 个定制 GROW 百分位数。我们还测试了非定制标准的性能,即 Hadlock 胎儿体重大于第 90 百分位数,新生儿体重大于 4 千克。我们计算了整个人群以及不同孕产妇体重指数群体的诊断特征:研究队列由 26 527 名孕妇组成,这些孕妇平均在妊娠 256 天时进行扫描,20 天后分娩,中位数为 276 天(四分位距为 15)。按定制百分位数计算,共有 2241 名(8.4%)新生儿的胎龄偏大,其中 1459 名(65.1%)扫描估计胎儿体重大于第 90 个百分位数,假阳性率为 8.6%,阳性预测值为 41.0%。在 912 例(3.4%)因疑似巨大胎儿而进行扫描的孕妇中,有 293 例(32.1%)婴儿出生时的胎龄较大,阳性预测值为 50.3%,灵敏度为 77.1%,假阳性率为 36.0%。如果将体重指数从低(2)到高(>30kg/m2)的亚组进行比较,灵敏度从 55.6% 提高到 67.8%,假阳性率从 5.2% 提高到 11.5%,阳性预测值从 32.1% 提高到 42.3%。共有 2585 名(9.7%)婴儿为巨大儿(出生体重大于 4 千克),其中 1058 名(40.9%)婴儿在产前根据哈德洛克生长标准为胎龄巨大儿(大于第 90 百分位数),假阳性率为 4.9%,阳性预测值为 41.0%。亚组分析显示,与非定制标准相比,定制标准在低体重指数(30;诊断几率为 16.2 vs 8.8)方面表现更好:结论:在任何适应症下,孕晚期超声估测胎儿体重都能很好地识别和预测胎儿出生时的巨大胎龄,而且在使用定制标准时,其效果会更好。对疑似巨大胎儿进行超声检查时,检测率会更高,但假阳性诊断的风险也更高。我们的研究结果为妇女和临床医生提供了信息,有助于产前决定是否让疑似巨大胎儿出生。
{"title":"Accuracy of antenatal ultrasound in predicting large-for-gestational-age babies: population-based cohort study","authors":"Lauren J. Ewington PhD ,&nbsp;Oliver Hugh MSc ,&nbsp;Emily Butler BSc (Hons) ,&nbsp;Siobhan Quenby MD, FRCOG ,&nbsp;Jason Gardosi MD, FRCOG","doi":"10.1016/j.ajog.2024.04.052","DOIUrl":"10.1016/j.ajog.2024.04.052","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;Pregnancies with large-for-gestational-age fetuses are at increased risk of adverse maternal and neonatal outcomes. There is uncertainty about how to manage birth in such pregnancies. Current guidelines recommend a discussion with women of the pros and cons of options, including expectant management, induction of labor, and cesarean delivery. For women to make an informed decision about birth, antenatal detection of large for gestational age is essential.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;div&gt;To investigate the ability of antenatal ultrasound scans to predict large for gestational age at birth.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Study Design&lt;/h3&gt;&lt;div&gt;In this retrospective cohort study, we analyzed data from a routinely collected database from the West Midlands, United Kingdom. We included pregnancies that had an antenatal ultrasound-estimated fetal weight between 35+0 and 38+0 weeks gestation for any indication and a subgroup where the reason for the scan was that the fetus was suspected to be big. Large for gestational age was defined as &gt;90th customized GROW percentile for estimated fetal weight as well as neonatal weight. In addition, we tested the performance of an uncustomized standard, with Hadlock fetal weight &gt;90th percentile and neonatal weight &gt;4 kg. We calculated diagnostic characteristics for the whole population and groups with different maternal body mass indexes.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;The study cohort consisted of 26,527 pregnancies, which, on average, had a scan at 36+4 weeks gestation and delivered 20 days later at a median of 39+3 weeks (interquartile range 15). In total, 2241 (8.4%) of neonates were large for gestational age by customized percentiles, of which 1459 (65.1%) had a scan estimated fetal weight &gt;90th percentile, with a false positive rate of 8.6% and a positive predictive value of 41.0%. In the subgroup of 912 (3.4%) pregnancies scanned for a suspected large fetus, 293 (32.1%) babies were large for gestational age at birth, giving a positive predictive value of 50.3%, with a sensitivity of 77.1% and false positive rate of 36.0%. When comparing subgroups from low (&lt;18.5 kg/m&lt;sup&gt;2&lt;/sup&gt;) to high body mass index (&gt;30 kg/m&lt;sup&gt;2&lt;/sup&gt;), sensitivity increased from 55.6% to 67.8%, false positive rate from 5.2% to 11.5%, and positive predictive value from 32.1% to 42.3%. A total of 2585 (9.7%) babies were macrosomic (birthweight &gt;4 kg), and of these, 1058 (40.9%) were large for gestational age (&gt;90th percentile) antenatally by Hadlock’s growth standard, with a false positive rate of 4.9% and a positive predictive value 41.0%. Analysis within subgroups showed better performance by customized than uncustomized standards for low body mass index (&lt;18.5; diagnostic odds ratio, 23.0 vs 6.4) and high body mass index (&gt;30; diagnostic odds ratio, 16.2 vs 8.8).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;Late third-trimester ultrasound estimation of fetal weight for any indica","PeriodicalId":7574,"journal":{"name":"American journal of obstetrics and gynecology","volume":"232 2","pages":"Pages 210.e1-210.e10"},"PeriodicalIF":8.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140896753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immediate vs delayed postpartum insertion of long-acting reversible contraception methods: meta-analysis of randomized controlled trials 产后立即与延迟放置长效可逆避孕方法:随机对照试验荟萃分析。
IF 8.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.ajog.2024.09.019
Henrique Provinciatto MD , Yasmin Jardim Meirelles Dias MD , Sabrina Lara Abonizio Magdalena MS , Marcus Vinicius Barbosa Moreira MS , Lucas Rezende de Freitas MS , Caroline Cristine Almeida Balieiro MS , Cristina Aparecida Falbo Guazzelli PhD , Edward Araujo Júnior PhD

Objective

We aimed to conduct a meta-analysis of randomized trials comparing the immediate vs delayed provision of long-acting reversible contraceptives in postpartum subjects, focusing on short-interval pregnancies, utilization rates, and adverse events.

Data sources

Cochrane Central, Embase, PubMed, and ClinicalTrials.gov were systematically searched from inception up to December 19, 2023, without filters or language limitation.

Study eligibility criteria

We selected randomized controlled trials assessing the immediate insertion of long-acting reversible contraceptives in women during postpartum period in comparison with the delayed provision.

Study appraisal and synthesis methods

We calculated relative risks with 95% confidence intervals to analyze the primary outcome of utilization rates and secondary endpoints, including initiation rates, pregnancy, any breastfeeding, exclusive breastfeeding, and serious adverse events. A random-effects model was employed in the R software. Moreover, we assessed the risk of bias of selected randomized controlled trials using version 2 of the Cochrane Risk of Bias Assessment Tool.

Results

We included 24 randomized trials comprising 2507 participants, of whom 1293 (51.6%) were randomized to the immediate insertion. Postpartum women in the immediate group had lower risk of pregnancy (relative risk 0.16; 95% confidence interval 0.04–0.71; P=.02) compared with delayed group, and higher rates of long-acting reversible contraceptives at 6 months of follow-up (relative risk 1.23; 95% confidence interval 1.09–1.37; P<.01).

Conclusion

Inserting long-acting reversible contraceptives before hospital discharge was associated with a reduction in the risk of pregnancy, and increased rates of its utilization at 6 months of follow-up. This intervention may be an effective contraception strategy for postpartum women.
目的我们旨在对产后受试者立即使用长效可逆避孕药与延迟使用长效可逆避孕药的随机试验进行荟萃分析,重点关注短间隔妊娠、使用率和不良事件。数据来源我们对Cochrane Central、Embase、PubMed和ClinicalTrials.gov进行了系统检索,检索时间从开始到2023年12月19日,没有筛选条件或语言限制。研究筛选标准我们选择了一些随机对照试验,这些试验评估了在产后妇女中立即放置长效可逆避孕药与延迟提供长效可逆避孕药的对比情况。研究评估与分析方法我们计算了相对风险系数(RR)和 95% 的置信区间,以分析使用率这一主要结果和次要终点,包括开始使用率、怀孕、任何母乳喂养、纯母乳喂养和严重不良事件。R 软件采用了随机效应模型。此外,我们还使用 Cochrane 偏倚风险评估工具的第 2 版评估了所选 RCT 的偏倚风险。与延迟组相比,立即组产后妇女的妊娠风险更低(RR 0.16; 95% CI 0.04-0.71; P = 0.02),随访 6 个月时长效可逆避孕药的使用率更高(RR 1.23; 95% CI 1.09-1.37; P < 0.01)。这种干预措施可能是产后妇女的一种有效避孕策略。
{"title":"Immediate vs delayed postpartum insertion of long-acting reversible contraception methods: meta-analysis of randomized controlled trials","authors":"Henrique Provinciatto MD ,&nbsp;Yasmin Jardim Meirelles Dias MD ,&nbsp;Sabrina Lara Abonizio Magdalena MS ,&nbsp;Marcus Vinicius Barbosa Moreira MS ,&nbsp;Lucas Rezende de Freitas MS ,&nbsp;Caroline Cristine Almeida Balieiro MS ,&nbsp;Cristina Aparecida Falbo Guazzelli PhD ,&nbsp;Edward Araujo Júnior PhD","doi":"10.1016/j.ajog.2024.09.019","DOIUrl":"10.1016/j.ajog.2024.09.019","url":null,"abstract":"<div><h3>Objective</h3><div>We aimed to conduct a meta-analysis of randomized trials comparing the immediate vs delayed provision of long-acting reversible contraceptives in postpartum subjects, focusing on short-interval pregnancies, utilization rates, and adverse events.</div></div><div><h3>Data sources</h3><div>Cochrane Central, Embase, PubMed, and ClinicalTrials.gov were systematically searched from inception up to December 19, 2023, without filters or language limitation.</div></div><div><h3>Study eligibility criteria</h3><div>We selected randomized controlled trials assessing the immediate insertion of long-acting reversible contraceptives in women during postpartum period in comparison with the delayed provision.</div></div><div><h3>Study appraisal and synthesis methods</h3><div>We calculated relative risks with 95% confidence intervals to analyze the primary outcome of utilization rates and secondary endpoints, including initiation rates, pregnancy, any breastfeeding, exclusive breastfeeding, and serious adverse events. A random-effects model was employed in the R software. Moreover, we assessed the risk of bias of selected randomized controlled trials using version 2 of the Cochrane Risk of Bias Assessment Tool.</div></div><div><h3>Results</h3><div>We included 24 randomized trials comprising 2507 participants, of whom 1293 (51.6%) were randomized to the immediate insertion. Postpartum women in the immediate group had lower risk of pregnancy (relative risk 0.16; 95% confidence interval 0.04–0.71; <em>P</em>=.02) compared with delayed group, and higher rates of long-acting reversible contraceptives at 6 months of follow-up (relative risk 1.23; 95% confidence interval 1.09–1.37; <em>P</em>&lt;.01).</div></div><div><h3>Conclusion</h3><div>Inserting long-acting reversible contraceptives before hospital discharge was associated with a reduction in the risk of pregnancy, and increased rates of its utilization at 6 months of follow-up. This intervention may be an effective contraception strategy for postpartum women.</div></div>","PeriodicalId":7574,"journal":{"name":"American journal of obstetrics and gynecology","volume":"232 2","pages":"Pages 139-149.e16"},"PeriodicalIF":8.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142275296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Approach to radical hysterectomy for cervical cancer after the Laparoscopic Approach to Cervical Cancer trial and associated complications: a National Surgical Quality Improvement Program study LACC 试验后宫颈癌根治性切除术的方法及相关并发症:NSQIP 研究。
IF 8.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.ajog.2024.08.008
Gabriel Levin MD , Pedro T. Ramirez MD , Jason D. Wright MD , Brian M. Slomovitz MD , Kacey M. Hamilton MD , Rebecca J. Schneyer MD , Moshe Barnajian MD , Yosef Nasseri MD , Matthew T. Siedhoff MD, MSCR , Kelly N. Wright MD , Raanan Meyer MD
<div><h3>Background</h3><div>The Laparoscopic Approach to Cervical Cancer study results revolutionized our understanding of the best surgical management for this disease. After its publication, the guidelines state that the standard and recommended approach for radical hysterectomy is an open abdominal approach. Nevertheless, the effect of the Laparoscopic Approach to Cervical Cancer trial on real-world changes in the surgical approach to radical hysterectomy remains elusive.</div></div><div><h3>Objective</h3><div>This study aimed to investigate the trends and routes of radical hysterectomy and to evaluate postoperative complication rates before and after the Laparoscopic Approach to Cervical Cancer trial (2018).</div></div><div><h3>Study Design</h3><div>The National Surgical Quality Improvement Program registry was used to examine radical hysterectomy for cervical cancer performed between 2012 and 2022. This study excluded vaginal radical hysterectomies and simple hysterectomies. The primary outcome measures were the trends in the route of surgery (minimally invasive surgery vs laparotomy) and surgical complication rates, stratified by periods before and after the publication of the Laparoscopic Approach to Cervical Cancer trial in 2018 (2012–2017 vs 2019–2022). The secondary outcome measure was major complications associated specifically with the different routes of surgery.</div></div><div><h3>Results</h3><div>Of the 3611 patients included, 2080 (57.6%) underwent laparotomy, and 1531 (42.4%) underwent minimally invasive radical hysterectomy. There was a significant increase in the minimally invasive surgery approach from 2012 to 2017 (45.6% in minimally invasive surgery in 2012 to 75.3% in minimally invasive surgery in 2017; <em>P</em><.01) and a significant decrease in minimally invasive surgery from 2018 to 2022 (50.4% in minimally invasive surgery in 2018 to 11.4% in minimally invasive surgery in 2022; <em>P</em><.001). The rate of minor complications was lower in the period before the Laparoscopic Approach to Cervical Cancer trial than after the trial (317 [16.9%] vs 288 [21.3%], respectively; <em>P</em>=.002). The major complication rates were similar before and after the Laparoscopic Approach to Cervical Cancer trial (139 [7.4%] vs 78 [5.8%], respectively; <em>P</em>=.26). The rates of blood transfusions and superficial surgical site infections were lower in the period before the Laparoscopic Approach to Cervical Cancer trial than in the period after the trial (137 [7.3%] vs 133 [9.8%] [<em>P</em>=.012] and 20 [1.1%] vs 53 [3.9%] [<em>P</em><.001], respectively). In a comparison of minimally invasive surgery vs laparotomy radical hysterectomy during the entire study period, patients in the minimally invasive surgery group had lower rates of minor complications than in those in the laparotomy group (190 [12.4%] vs 472 [22.7%], respectively; <em>P</em><.001), and the rates of major complications were similar in both groups (100
背景:宫颈癌腹腔镜手术(LACC)研究结果彻底改变了我们对该疾病最佳手术治疗方法的认识。该研究发表后,指南规定根治性子宫切除术的标准和推荐方法是开腹手术。然而,LACC 试验对现实世界中根治性子宫切除术手术方法变化的影响仍然难以捉摸:我们旨在研究根治性子宫切除术的趋势和途径,并评估 LACC 试验(2018 年)前后的术后并发症发生率:我们利用国家手术质量改进计划注册表对2012-2022年间因宫颈癌实施的根治性子宫切除术进行了研究。我们排除了阴道根治性子宫切除术和单纯子宫切除术。主要结局指标是手术路径[微创手术(MIS)与开腹手术]和手术并发症发生率的趋势,按2018年LACC试验发表前后的时间段进行分层(2012-2017年与2019-2022年)。次要结局指标是与不同手术路径具体相关的主要并发症:在纳入的3611名患者中,2080人(57.6%)接受了开腹手术,1531人(42.4%)接受了MIS根治性子宫切除术。从2012年到2017年,MIS方法明显增加(2012年MIS占45.6%,2017年MIS占75.3%,p结论:LACC试验后,MIS根治性子宫切除术的比例骤然下降,但术后主要并发症的发生率没有变化。此外,子宫切除术的途径与术后主要并发症无关。
{"title":"Approach to radical hysterectomy for cervical cancer after the Laparoscopic Approach to Cervical Cancer trial and associated complications: a National Surgical Quality Improvement Program study","authors":"Gabriel Levin MD ,&nbsp;Pedro T. Ramirez MD ,&nbsp;Jason D. Wright MD ,&nbsp;Brian M. Slomovitz MD ,&nbsp;Kacey M. Hamilton MD ,&nbsp;Rebecca J. Schneyer MD ,&nbsp;Moshe Barnajian MD ,&nbsp;Yosef Nasseri MD ,&nbsp;Matthew T. Siedhoff MD, MSCR ,&nbsp;Kelly N. Wright MD ,&nbsp;Raanan Meyer MD","doi":"10.1016/j.ajog.2024.08.008","DOIUrl":"10.1016/j.ajog.2024.08.008","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;The Laparoscopic Approach to Cervical Cancer study results revolutionized our understanding of the best surgical management for this disease. After its publication, the guidelines state that the standard and recommended approach for radical hysterectomy is an open abdominal approach. Nevertheless, the effect of the Laparoscopic Approach to Cervical Cancer trial on real-world changes in the surgical approach to radical hysterectomy remains elusive.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;div&gt;This study aimed to investigate the trends and routes of radical hysterectomy and to evaluate postoperative complication rates before and after the Laparoscopic Approach to Cervical Cancer trial (2018).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Study Design&lt;/h3&gt;&lt;div&gt;The National Surgical Quality Improvement Program registry was used to examine radical hysterectomy for cervical cancer performed between 2012 and 2022. This study excluded vaginal radical hysterectomies and simple hysterectomies. The primary outcome measures were the trends in the route of surgery (minimally invasive surgery vs laparotomy) and surgical complication rates, stratified by periods before and after the publication of the Laparoscopic Approach to Cervical Cancer trial in 2018 (2012–2017 vs 2019–2022). The secondary outcome measure was major complications associated specifically with the different routes of surgery.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Of the 3611 patients included, 2080 (57.6%) underwent laparotomy, and 1531 (42.4%) underwent minimally invasive radical hysterectomy. There was a significant increase in the minimally invasive surgery approach from 2012 to 2017 (45.6% in minimally invasive surgery in 2012 to 75.3% in minimally invasive surgery in 2017; &lt;em&gt;P&lt;/em&gt;&lt;.01) and a significant decrease in minimally invasive surgery from 2018 to 2022 (50.4% in minimally invasive surgery in 2018 to 11.4% in minimally invasive surgery in 2022; &lt;em&gt;P&lt;/em&gt;&lt;.001). The rate of minor complications was lower in the period before the Laparoscopic Approach to Cervical Cancer trial than after the trial (317 [16.9%] vs 288 [21.3%], respectively; &lt;em&gt;P&lt;/em&gt;=.002). The major complication rates were similar before and after the Laparoscopic Approach to Cervical Cancer trial (139 [7.4%] vs 78 [5.8%], respectively; &lt;em&gt;P&lt;/em&gt;=.26). The rates of blood transfusions and superficial surgical site infections were lower in the period before the Laparoscopic Approach to Cervical Cancer trial than in the period after the trial (137 [7.3%] vs 133 [9.8%] [&lt;em&gt;P&lt;/em&gt;=.012] and 20 [1.1%] vs 53 [3.9%] [&lt;em&gt;P&lt;/em&gt;&lt;.001], respectively). In a comparison of minimally invasive surgery vs laparotomy radical hysterectomy during the entire study period, patients in the minimally invasive surgery group had lower rates of minor complications than in those in the laparotomy group (190 [12.4%] vs 472 [22.7%], respectively; &lt;em&gt;P&lt;/em&gt;&lt;.001), and the rates of major complications were similar in both groups (100","PeriodicalId":7574,"journal":{"name":"American journal of obstetrics and gynecology","volume":"232 2","pages":"Pages 208.e1-208.e11"},"PeriodicalIF":8.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141995101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
American journal of obstetrics and gynecology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1